Effectiveness of PTSD-treatment Compared to Integrated PTSD-PD-treatment in Adult Patients With Comorbid PTSD and BPD
PROSPER-B
Prediction and Outcome Study in PTSD and (Borderline) Personality Disorders
1 other identifier
interventional
126
1 country
1
Brief Summary
The goal of PROSPER-B is to study effectiveness of EMDR compared to integrated DBT-EMDR in treatment-seeking, adult patients with comorbid PTSD and Borderline Personality Disorder (BPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 24, 2019
CompletedFirst Posted
Study publicly available on registry
February 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2023
CompletedSeptember 23, 2020
September 1, 2020
3.8 years
January 24, 2019
September 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CAPS-5 (Clinician Administered PTSD Scale)
The CAPS-5 is a structured diagnostic interview to assess the frequency and severity of DSM-5 PTSD symptoms. The interview consists of 30 items, with higher scores indicating more severe symptomatology. CAPS-5 total symptom severity score is calculated by summing severity scores for the 20 DSM-5 PTSD symptoms. Similarly, CAPS-5 symptom cluster severity scores are calculated by summing the individual item severity scores for symptoms corresponding to a given DSM-5 cluster: Criterion B (items 1-5); Criterion C (items 6-7); Criterion D (items 8-14); and, Criterion E (items 15-20). A symptom cluster score may also be calculated for dissociation by summing items 19 and 20. To meet the criteria for PTSD diagnoses, at least one Criterion B and one Criterion C symptom, and two criterion D and E symptoms are required. Furthermore, Criterion F and G should be met.
12 months
Secondary Outcomes (13)
SCID-5-PD (Structured Interview for DSM-5 Personality Disorders)
12 months
PCL-5 (PTSD Checklist for DSM-5)
12 months
Outcome Questionnaire -45 (OQ-45)
12 months
Beck depression inventory (BDI)
12 months
AUDIT (Alcohol Use Disorders Identification Test)
12 months
- +8 more secondary outcomes
Study Arms (2)
PTSD-EMDR
ACTIVE COMPARATORPTSD treatment
Integrated DBT-EMDR
EXPERIMENTALIntegrated PTSD-PD-treatment
Interventions
EMDR is a PTSD treatment that specifically addresses troubling memories of and the personal meaning of the traumatic event and consists of 12 to 18 sessions in a maximum of 6 months.
DBT is a treatment for personality disorders (PD) focused on emotion regulation. It takes at least one group-session per week, and one individual coaching session every two weeks, for the duration of one year.
Eligibility Criteria
You may qualify if:
- Diagnosed with PTSD (309.81), and
- Diagnosed with a borderline personality disorder (301.83) or at least 4 BPD symptoms
- To be eligible for the study, both patients and healthy controls (for the MRI scans) have to:
- Be aged between 18 and 65 years
- Give written informed consent
- Speak / understand Dutch sufficiently
You may not qualify if:
- Current psychosis
- Comorbidity interfering with treatment or randomisation (severe outward aggression, antisocial PD, treatment interfering addiction or eating disorders, somatic problems)
- Primary diagnosis of paranoid, schizoid, schizotypal, narcissistic, histrionic or antisocial PD
- Mental retardation
- Pregnancy
- Metal implants (such as pacemakers, etc.);
- Somatic disorders interfering with brain functioning
- Claustrophobia
- High dose use of benzodiazepines
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arkinlead
- Sinai Centrum, Arkin, The Netherlandscollaborator
- Amsterdam UMC, location VUmccollaborator
- Stichting Steunfonds Joodse Geestelijke Gezondheidszorg (SSF JGG)collaborator
- Ziekenhuis Amstellandcollaborator
- Meander Medisch Centrumcollaborator
Study Sites (1)
Sinai Centrum
Amstelveen, Noord-Holand, 1180EB, Netherlands
Related Publications (26)
Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005 Feb;162(2):214-27. doi: 10.1176/appi.ajp.162.2.214.
PMID: 15677582BACKGROUNDHarned MS, Korslund KE, Linehan MM. A pilot randomized controlled trial of Dialectical Behavior Therapy with and without the Dialectical Behavior Therapy Prolonged Exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD. Behav Res Ther. 2014 Apr;55:7-17. doi: 10.1016/j.brat.2014.01.008. Epub 2014 Feb 11.
PMID: 24562087BACKGROUNDEhlers A, Clark DM, Hackmann A, McManus F, Fennell M. Cognitive therapy for post-traumatic stress disorder: development and evaluation. Behav Res Ther. 2005 Apr;43(4):413-31. doi: 10.1016/j.brat.2004.03.006.
PMID: 15701354BACKGROUNDLanius RA, Vermetten E, Loewenstein RJ, Brand B, Schmahl C, Bremner JD, Spiegel D. Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. Am J Psychiatry. 2010 Jun;167(6):640-7. doi: 10.1176/appi.ajp.2009.09081168. Epub 2010 Apr 1.
PMID: 20360318BACKGROUNDNijdam MJ, de Vries GJ, Gersons BP, Olff M. Response to psychotherapy for posttraumatic stress disorder: the role of pretreatment verbal memory performance. J Clin Psychiatry. 2015 Aug;76(8):e1023-8. doi: 10.4088/JCP.14m09438.
PMID: 26335088BACKGROUNDvan Rooij SJ, Kennis M, Vink M, Geuze E. Predicting Treatment Outcome in PTSD: A Longitudinal Functional MRI Study on Trauma-Unrelated Emotional Processing. Neuropsychopharmacology. 2016 Mar;41(4):1156-65. doi: 10.1038/npp.2015.257. Epub 2015 Aug 20.
PMID: 26289143BACKGROUNDCloitre M, Stovall-McClough KC, Miranda R, Chemtob CM. Therapeutic alliance, negative mood regulation, and treatment outcome in child abuse-related posttraumatic stress disorder. J Consult Clin Psychol. 2004 Jun;72(3):411-6. doi: 10.1037/0022-006X.72.3.411.
PMID: 15279525BACKGROUNDBryant RA, Felmingham K, Kemp A, Das P, Hughes G, Peduto A, Williams L. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med. 2008 Apr;38(4):555-61. doi: 10.1017/S0033291707002231. Epub 2007 Nov 16.
PMID: 18005496BACKGROUNDBrewin CR, Andrews B, Valentine JD. Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults. J Consult Clin Psychol. 2000 Oct;68(5):748-66. doi: 10.1037//0022-006x.68.5.748.
PMID: 11068961BACKGROUNDBisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2007 Jul 18;(3):CD003388. doi: 10.1002/14651858.CD003388.pub3.
PMID: 17636720BACKGROUNDBisson JI, Roberts NP, Andrew M, Cooper R, Lewis C. Psychological therapies for chronic post-traumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2013 Dec 13;2013(12):CD003388. doi: 10.1002/14651858.CD003388.pub4.
PMID: 24338345BACKGROUNDClarke SB, Rizvi SL, Resick PA. Borderline personality characteristics and treatment outcome in cognitive-behavioral treatments for PTSD in female rape victims. Behav Ther. 2008 Mar;39(1):72-8. doi: 10.1016/j.beth.2007.05.002. Epub 2007 Oct 22.
PMID: 18328872BACKGROUNDFeeny NC, Zoellner LA, Foa EB. Treatment outcome for chronic PTSD among female assault victims with borderline personality characteristics: a preliminary examination. J Pers Disord. 2002 Feb;16(1):30-40. doi: 10.1521/pedi.16.1.30.22555.
PMID: 11881159BACKGROUNDFrias A, Palma C. Comorbidity between post-traumatic stress disorder and borderline personality disorder: a review. Psychopathology. 2015;48(1):1-10. doi: 10.1159/000363145. Epub 2014 Sep 9.
PMID: 25227722BACKGROUNDHembree EA, Cahill SP, Foa EB. Impact of personality disorders on treatment outcome for female assault survivors with chronic posttraumatic stress disorder. J Pers Disord. 2004 Feb;18(1):117-27. doi: 10.1521/pedi.18.1.117.32767.
PMID: 15061348BACKGROUNDRoberts BW, Luo J, Briley DA, Chow PI, Su R, Hill PL. A systematic review of personality trait change through intervention. Psychol Bull. 2017 Feb;143(2):117-141. doi: 10.1037/bul0000088. Epub 2017 Jan 5.
PMID: 28054797BACKGROUNDKredlow MA, Szuhany KL, Lo S, Xie H, Gottlieb JD, Rosenberg SD, Mueser KT. Cognitive behavioral therapy for posttraumatic stress disorder in individuals with severe mental illness and borderline personality disorder. Psychiatry Res. 2017 Mar;249:86-93. doi: 10.1016/j.psychres.2016.12.045. Epub 2017 Jan 4.
PMID: 28086181BACKGROUNDStoffers JM, Vollm BA, Rucker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD005652. doi: 10.1002/14651858.CD005652.pub2.
PMID: 22895952BACKGROUNDRaabe S, Ehring T, Marquenie L, Olff M, Kindt M. Imagery Rescripting as stand-alone treatment for posttraumatic stress disorder related to childhood abuse. J Behav Ther Exp Psychiatry. 2015 Sep;48:170-6. doi: 10.1016/j.jbtep.2015.03.013. Epub 2015 Apr 4.
PMID: 25898289BACKGROUNDArntz A, Tiesema M, Kindt M. Treatment of PTSD: a comparison of imaginal exposure with and without imagery rescripting. J Behav Ther Exp Psychiatry. 2007 Dec;38(4):345-70. doi: 10.1016/j.jbtep.2007.10.006. Epub 2007 Oct 26.
PMID: 18005935BACKGROUNDFarrell JM, Shaw IA, Webber MA. A schema-focused approach to group psychotherapy for outpatients with borderline personality disorder: a randomized controlled trial. J Behav Ther Exp Psychiatry. 2009 Jun;40(2):317-28. doi: 10.1016/j.jbtep.2009.01.002. Epub 2009 Jan 14.
PMID: 19176222BACKGROUNDKuhner C, de Waal M, Steenkamp L, van Zwol I, Goudriaan A, Thomaes K. The impact of types of childhood maltreatment on the severity of PTSD and comorbid personality disorder symptoms. Eur J Psychotraumatol. 2025 Dec;16(1):2491172. doi: 10.1080/20008066.2025.2491172. Epub 2025 Apr 22.
PMID: 40261043DERIVEDSnoek A, Edens R, van Ballegooijen W, Dekker J, Beekman AT, Thomaes K. A network perspective on posttraumatic stress disorder and comorbid borderline personality disorder symptoms. Eur J Psychotraumatol. 2024;15(1):2367815. doi: 10.1080/20008066.2024.2367815. Epub 2024 Jul 3.
PMID: 38957149DERIVEDAarts I, Vriend C, Snoek A, van den End A, Blankers M, Beekman ATF, Dekker J, van den Heuvel OA, Thomaes K. Neural correlates of treatment effect and prediction of treatment outcome in patients with PTSD and comorbid personality disorder: study design. Borderline Personal Disord Emot Dysregul. 2021 May 5;8(1):13. doi: 10.1186/s40479-021-00156-8.
PMID: 33947471DERIVEDSnoek A, Beekman ATF, Dekker J, Aarts I, van Grootheest G, Blankers M, Vriend C, van den Heuvel O, Thomaes K. A randomized controlled trial comparing the clinical efficacy and cost-effectiveness of eye movement desensitization and reprocessing (EMDR) and integrated EMDR-Dialectical Behavioural Therapy (DBT) in the treatment of patients with post-traumatic stress disorder and comorbid (Sub)clinical borderline personality disorder: study design. BMC Psychiatry. 2020 Aug 6;20(1):396. doi: 10.1186/s12888-020-02713-x.
PMID: 32762677DERIVEDStorebo OJ, Stoffers-Winterling JM, Vollm BA, Kongerslev MT, Mattivi JT, Jorgensen MS, Faltinsen E, Todorovac A, Sales CP, Callesen HE, Lieb K, Simonsen E. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5(5):CD012955. doi: 10.1002/14651858.CD012955.pub2.
PMID: 32368793DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Thomaes, MD/PhD
Sinai Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Assessments will be performed by allocation-blind assessors. Upon seeing a participant for an assessment, assessors are instructed to immediately state that participants are not allowed to discuss aspects of the treatment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2019
First Posted
February 7, 2019
Study Start
June 1, 2018
Primary Completion
April 2, 2022
Study Completion
April 2, 2023
Last Updated
September 23, 2020
Record last verified: 2020-09